Mandate

Vinge advises SCA in connection with the financing for the acquisition of BSN Medical from EQT

December 21, 2016

Vinge has advised SCA in the negotiations with the banks regarding financing in connection with SCA’s acquisition of the German company BSN Medical, a leading medico technical company, from EQT.

BSN Medical develops, manufactures, markets and sells products within treatment of wounds, compression treatment and orthopaedics. The enterprise value amounts to EUR 2 740 000 000 (based on an estimated net debt as per 31 December 2016). The acquisition will be completely loan-financed and SCA has a binding credit assurance available. Clifford Chance in Germany represented SCA in relation to the acquisition and the banks were represented by Clifford Chance in London.

The transaction is conditional upon the salient regulatory approvals and is expected to be completed during the second quarter of 2017. The financial conditions governing the transaction have not been made public.
 
Vinge’s team consisted of Mikael Ståhl, Helena Håkansson and Lionardo Ojeda.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025